AMICUS THERAPEUTICS, INC. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Amicus Therapeutics, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2017 to Q3 2023.
  • Amicus Therapeutics, Inc. Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 -$4.93M -100% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $0 -$4.93M -100% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $0 -$4.93M -100% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $4.94M +$9K +0.18% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $4.93M +$34K +0.69% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $4.93M +$34K +0.69% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.93M +$34K +0.69% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.93M +$34K +0.69% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $4.9M -$155K -3.07% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.9M -$155K -3.07% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $4.9M -$155K -3.07% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $4.9M -$155K -3.07% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $5.05M -$1.41M -21.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $5.05M -$1.41M -21.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $5.05M -$1.41M -21.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $5.05M -$1.41M -21.9% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $6.47M $0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $6.47M $0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $6.47M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $6.47M $0 0% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $6.47M Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $6.47M Jun 30, 2018 10-Q 2018-08-07
Q4 2017 $6.47M Dec 31, 2017 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.